Operating at the intersection of science, technology and business strategy, Health Advances provides clients with innovative solutions based on deep industry insight, analytical rigor and an objective perspective.

Autoimmune Diseases Cardio and Peripheral Vascular Diseases CNS Diseases Dermatology and Wound Care Diabetes, Obesity, and Endocrine Diseases Genitourinary Diseases Infectious Diseases Oncology and Hematology Ophthalmology and Otolaryngology Orthopedics Respiratory Conditions Women's Health Other Clinical Areas Select Clinical Trial Strategy Due Diligence Launch Strategy and Salesforce Lifecycle Management Market Assessment and Forecasting Partnering and Licensing Portfolio Planning Reimbursement and Pricing Strategy Product Positioning Strategic and Business Planning Technology Commercialization Valuation and Financial Analysis Select Biotechnology Diagnostics Drug Delivery Life Sciences Medical Devices Not-for-Profit Organizations Personalized Medicine Pharmaceuticals Private Equity Venture-Backed Companies Select Health Advances is leading five panels at the BIO annual meeting being held in Boston, MA from June 18-22, 2012. Join our leadership team and their expert panelists as they address your greatest industry challenges. June 19 Personalizing Medicine through Health IT Solutions: A New Commercial Value Driver Novel Securities to Leverage Company Assets Commercialization of Personalized Medicine: Stakeholders' Recipe for Success June 20 Is Big Pharma the Preferred Partner for Orphan Drug Biotechs? June 21 Disease Foundation-Funded Drug Development Partnerships: Structuring for Success learn more   MedTech's New Economic Value Proposition Susan Posner, Vice President, delivered a presentation and moderated a panel at MassMEDIC's 16th annual conference. learn more. learn more about our expertise in medical devices. Health Advances Offers Perspectives on Specialty Markets Big Pharma is no longer a stranger to highly lucrative, specialist-led markets such as rheumatology, oncology, and even orphan/genetic diseases. But shifting market dynamics require careful consideration of the overall goal of a specialty driven strategy and identification of key factors for success. learn more. read the article. learn more about our expertise in biotechnology. learn more about our expertise in pharmaceuticals. World Companion Diagnostics Summit Kristin Pothier, Partner, delivered a presentation titled "Commercializing Personalized Medicine: Navigating Reality in Multiple Markets" at the 5th World Companion Diagnostics Summit in Frankfurt, Germany. learn more. learn more about our expertise in the diagnostics area. Health Advances All Rights Reserved.     Privacy    Terms of Use find us on facebook